• 1. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines

Professional Introduction to N-(Piperidin-4-ylmethyl)acetamide (CAS No. 71207-33-5)

N-(Piperidin-4-ylmethyl)acetamide is a significant compound in the field of pharmaceutical chemistry, characterized by its unique structural and functional properties. This compound, identified by the CAS number 71207-33-5, has garnered considerable attention due to its potential applications in drug development and bioorganic synthesis. The presence of a piperidine ring and an acetamide moiety imparts distinct chemical reactivity, making it a valuable intermediate in the synthesis of various bioactive molecules.

The piperidine ring, a six-membered heterocyclic structure containing nitrogen, is well-known for its ability to enhance the solubility and metabolic stability of pharmaceutical compounds. In particular, the 4-substituted piperidine derivative exhibits favorable pharmacokinetic profiles, which are crucial for the design of orally active drugs. The acetamide group, on the other hand, contributes to the compound's amide bond-forming capabilities, facilitating further chemical modifications and derivatization. These structural features make N-(Piperidin-4-ylmethyl)acetamide a versatile building block in medicinal chemistry.

Recent advancements in the field of drug discovery have highlighted the importance of scaffold-hopping strategies, where novel molecular frameworks are explored to overcome resistance mechanisms and improve therapeutic efficacy. N-(Piperidin-4-ylmethyl)acetamide has been employed in such strategies due to its ability to serve as a versatile precursor for generating structurally diverse analogs. For instance, researchers have utilized this compound to develop novel inhibitors targeting enzymes involved in inflammatory pathways. The incorporation of the piperidine moiety into these inhibitors has been shown to enhance binding affinity and selectivity, leading to more effective therapeutic outcomes.

In addition to its role in enzyme inhibition, N-(Piperidin-4-ylmethyl)acetamide has been explored in the development of central nervous system (CNS) drugs. Piperidine derivatives are particularly interesting in this context due to their ability to cross the blood-brain barrier (BBB). The 4-substituted piperidine scaffold has been found to enhance CNS penetration, making it an attractive scaffold for neuropharmacological applications. Studies have demonstrated that derivatives of N-(Piperidin-4-ylmethyl)acetamide exhibit promising activity against neurological disorders such as depression and anxiety. These findings underscore the compound's potential as a lead molecule in CNS drug discovery.

The synthesis of N-(Piperidin-4-ylmethyl)acetamide involves well-established organic chemistry techniques, including nucleophilic substitution reactions and condensation processes. The synthesis typically begins with the preparation of piperidin-4-methanol, which is then converted into the corresponding acetamide derivative through acetylation. This synthetic route is efficient and scalable, making it suitable for industrial production. Recent improvements in synthetic methodologies have focused on enhancing yield and purity while minimizing environmental impact. Green chemistry principles have been increasingly applied, leading to more sustainable synthetic protocols.

From a computational chemistry perspective, N-(Piperidin-4-ylmethyl)acetamide has been extensively studied using molecular modeling techniques. These studies aim to elucidate its interactions with biological targets at the atomic level. Advanced computational methods such as molecular dynamics simulations and quantum mechanical calculations have provided insights into the compound's binding mode and energetics. This information is crucial for rational drug design and optimization. By integrating experimental data with computational predictions, researchers can develop more accurate models for predicting biological activity.

The pharmacological profile of N-(Piperidin-4-ylmethyl)acetamide has been thoroughly investigated in preclinical studies. These studies have revealed that the compound exhibits moderate affinity for several neurotransmitter receptors, including serotonin receptors. This property makes it a potential candidate for developing novel antidepressants and anxiolytics. Additionally, preliminary studies suggest that derivatives of this compound may exhibit anti-inflammatory effects by modulating cytokine production pathways. Such findings highlight the broad therapeutic potential of piperidine-based scaffolds.

In conclusion, N-(Piperidin-4-ylmethyl)acetamide (CAS No. 71207-33-5) is a multifaceted compound with significant applications in pharmaceutical research and drug development. Its unique structural features make it a valuable intermediate for synthesizing bioactive molecules targeting various therapeutic areas. Recent research has demonstrated its potential in developing novel CNS drugs and enzyme inhibitors. The compound's favorable pharmacokinetic properties and synthetic accessibility further enhance its appeal as a lead molecule in medicinal chemistry. As research continues to uncover new applications for this compound, it is expected to play an increasingly important role in future drug discovery efforts.

• 51870-99-6( )
• 69131-12-0(Acetamide, N-[(2-methylcyclopentyl)methyl]-, trans- (9CI))
• 90346-06-8(N-(Piperidin-3-ylmethyl)acetamide)
• 25651-96-1(Acetamide,N-(2-ethylhexyl)-)
• 227465-47-6(Acetamide,N-[[4-(aminomethyl)-4-piperidinyl]methyl]-)
• 70924-83-3(N-[[4-(acetamidomethyl)cyclohexyl]methyl]acetamide)
• 69131-27-7(Acetamide, N-[(2-methylcyclopentyl)methyl]-, cis- (9CI))
• 361343-40-0(Acetamide, N-(cyclooctylmethyl)-)
• 949556-44-9(Acetamide, N-[[4-(aminomethyl)cyclohexyl]methyl]-)
• 70922-35-9(N-(2-piperidin-4-ylethyl)acetamide)